GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) is characterized by neurodegeneration, cognitive impairment, and memory loss.
• Previous research linked quercetin to the induction of growth arrest and DNA damage-inducible gene 34 (GADD34), impacting eukaryotic translation initiation factor 2α (eIF2α) phosphorylation and activating transcription factor 4 (ATF4) signaling.
• The specific role of GADD34 in cognitive function and memory in AD remains unclear.

Purpose of the Study:

• To investigate the direct impact of GADD34 on memory function in the context of Alzheimer's disease.
• To explore the potential of GADD34 as a therapeutic target for memory deficits in AD.

Main Methods:

• Administration of truncated GADD34 (GADD34.5) via direct brain injection in a mouse model of AD.
• Evaluation of memory performance using novel object recognition and novel object location tests following hippocampal injection.
• Assessment of contextual fear memory using a fear conditioning test after amygdala injection.

Main Results:

• Hippocampal injection of GADD34.5 did not enhance novel object recognition but improved novel object location memory in AD model mice.
• Amygdala injection of GADD34.5 maintained contextual fear memory in the fear conditioning test.
• These findings indicate GADD34's efficacy in improving specific types of memory in AD by inhibiting eIF2α phosphorylation.

Conclusions:

• GADD34 plays a significant role in preventing memory loss associated with Alzheimer's disease, particularly in spatial cognition and contextual fear conditioning.
• The mechanism involves the suppression of eIF2α phosphorylation in the brain.
• Quercetin, by increasing GADD34 expression, presents a potential dietary strategy for the preventative application in Alzheimer's disease.